In 2020, she and her team went on to discover that variants in APOE4 are a major susceptibility gene for Alzheimer’s disease, and that individuals carrying APOE4 are distinguished from those without by breakdown of the blood–brain barrier in the hippocampus and medial temporal lobe. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.